M A Katzman

Summary

Affiliation: University of Toronto
Country: Canada

Publications

  1. ncbi request reprint Pharmacotherapy of post-traumatic stress disorder: a family practitioners guide to management of the disease
    Martin A Katzman
    Start Clinic for the Treatment of Mood and Anxiety Disorders, 790 Bay St Suite 1110, Toronto, Ontario, M5G 1N8, Canada
    Expert Rev Neurother 5:129-39. 2005
  2. ncbi request reprint Treatments for generalized anxiety disorder
    Lukasz Struzik
    Faculty of Medicine, University of Toronto, 1909 Beechknoll Ave, Mississauga, Ontario, L4W 2G4, Canada
    Expert Rev Neurother 4:285-94. 2004
  3. ncbi request reprint Beyond shy: when to suspect social anxiety disorder
    Jessica Rosenthal
    START Clinic for Mood and Anxiety Disorders, Toronto, Ontario, Canada
    J Fam Pract 56:369-74. 2007
  4. pmc Weight gain and psychiatric treatment: Is there a role for green tea and conjugated linoleic acid?
    Martin A Katzman
    START Clinic for the Mood and Anxiety Disorders, Toronto, Canada
    Lipids Health Dis 6:14. 2007
  5. pmc A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome
    A Venket Rao
    Integrative Care Centre of Toronto, 3600 Ellesmere Road, Unit 4, Toronto, Ontario M1C 4Y8, Canada
    Gut Pathog 1:6. 2009
  6. pmc Stability of methylnicotinate in aqueous solution as utilized in the 'niacin patch test'
    Brian M Ross
    Northern Ontario School of Medicine, Lakehead University, Thunder Bay, Ontario, Canada
    BMC Res Notes 1:89. 2008
  7. doi request reprint Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: a long-term, randomized, placebo-controlled trial
    Martin A Katzman
    START Clinic for Mood and Anxiety Disorders, Toronto, Ontario, Canada
    Int Clin Psychopharmacol 26:11-24. 2011
  8. doi request reprint Current considerations in the treatment of generalized anxiety disorder
    Martin A Katzman
    START Stress, Trauma, Anxiety, Rehabilitation, and Treatment Clinic for Mood and Anxiety Disorders, Toronto, Ontario, Canada
    CNS Drugs 23:103-20. 2009
  9. doi request reprint Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial
    M A Katzman
    START Clinic for Mood and Anxiety Disorders, Canada
    J Anxiety Disord 22:1480-6. 2008
  10. ncbi request reprint Paroxetine versus placebo and other agents for depressive disorders: a systematic review and meta-analysis
    Martin A Katzman
    Faculty of Medicine, Department of Psychiatry, University of Toronto, Ontario, Canada
    J Clin Psychiatry 68:1845-59. 2007

Collaborators

  • Lukasz Struzik
  • Kevin D Kjernisted
  • Roger McIntyre
  • Jessica Rosenthal
  • A Venket Rao
  • Brian M Ross
  • Leslie Jacobs
  • Monica Vermani
  • John M Berardi
  • Christina Iorio
  • Alan C Logan
  • Tracey M Beaulne
  • Alison C Bested
  • Brian Kong
  • Madalyn Marcus
  • Irena Milosevic
  • Fraser Smith

Detail Information

Publications15

  1. ncbi request reprint Pharmacotherapy of post-traumatic stress disorder: a family practitioners guide to management of the disease
    Martin A Katzman
    Start Clinic for the Treatment of Mood and Anxiety Disorders, 790 Bay St Suite 1110, Toronto, Ontario, M5G 1N8, Canada
    Expert Rev Neurother 5:129-39. 2005
    ..Pharmacologic therapy instituted at the time of acute psychologic trauma shows promise for the prevention of post-traumatic stress disorder in the future and warrants further study...
  2. ncbi request reprint Treatments for generalized anxiety disorder
    Lukasz Struzik
    Faculty of Medicine, University of Toronto, 1909 Beechknoll Ave, Mississauga, Ontario, L4W 2G4, Canada
    Expert Rev Neurother 4:285-94. 2004
    ..Based on current evidence, the recommended approach to achieving long-term benefits for patients with generalized anxiety disorder is antidepressant therapy with paroxetine or venlafaxine in combination with cognitive behavioral therapy...
  3. ncbi request reprint Beyond shy: when to suspect social anxiety disorder
    Jessica Rosenthal
    START Clinic for Mood and Anxiety Disorders, Toronto, Ontario, Canada
    J Fam Pract 56:369-74. 2007
  4. pmc Weight gain and psychiatric treatment: Is there a role for green tea and conjugated linoleic acid?
    Martin A Katzman
    START Clinic for the Mood and Anxiety Disorders, Toronto, Canada
    Lipids Health Dis 6:14. 2007
    ..Since weight gain is a common and undesirable side-effect with psychiatric medications, our observation strongly suggests the need for controlled clinical trials using these agents...
  5. pmc A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome
    A Venket Rao
    Integrative Care Centre of Toronto, 3600 Ellesmere Road, Unit 4, Toronto, Ontario M1C 4Y8, Canada
    Gut Pathog 1:6. 2009
    ..01). These results lend further support to the presence of a gut-brain interface, one that may be mediated by microbes that reside or pass through the intestinal tract...
  6. pmc Stability of methylnicotinate in aqueous solution as utilized in the 'niacin patch test'
    Brian M Ross
    Northern Ontario School of Medicine, Lakehead University, Thunder Bay, Ontario, Canada
    BMC Res Notes 1:89. 2008
    ..To aid in the determination of how long solutions of the drug should be stored before discarding we have used a collection of aged batches of methylnicotinate to determine the stability of the drug in aqueous solution...
  7. doi request reprint Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: a long-term, randomized, placebo-controlled trial
    Martin A Katzman
    START Clinic for Mood and Anxiety Disorders, Toronto, Ontario, Canada
    Int Clin Psychopharmacol 26:11-24. 2011
    ..Quetiapine XR monotherapy reduced the risk of anxiety symptom recurrence in patients with GAD stabilized on quetiapine XR, with tolerability results consistent with the known profile of quetiapine...
  8. doi request reprint Current considerations in the treatment of generalized anxiety disorder
    Martin A Katzman
    START Stress, Trauma, Anxiety, Rehabilitation, and Treatment Clinic for Mood and Anxiety Disorders, Toronto, Ontario, Canada
    CNS Drugs 23:103-20. 2009
    ..Evidence from early clinical studies of the atypical antipsychotics in the treatment of anxiety and GAD indicate that they may have a potential role in the treatment of GAD, either as monotherapy or as augmentation to standard treatment...
  9. doi request reprint Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial
    M A Katzman
    START Clinic for Mood and Anxiety Disorders, Canada
    J Anxiety Disord 22:1480-6. 2008
    ..Generalized anxiety disorder (GAD) is a chronic disorder associated with significant morbidity and disability. Traditional therapies are associated with poor levels of remission, and often result in troublesome side effects...
  10. ncbi request reprint Paroxetine versus placebo and other agents for depressive disorders: a systematic review and meta-analysis
    Martin A Katzman
    Faculty of Medicine, Department of Psychiatry, University of Toronto, Ontario, Canada
    J Clin Psychiatry 68:1845-59. 2007
    ..To compare paroxetine with placebo and other antidepressants across multiple efficacy and tolerability outcomes...
  11. ncbi request reprint Acne vulgaris: nutritional factors may be influencing psychological sequelae
    Martin Katzman
    START Clinic for Mood and Anxiety Disorders, University of Toronto, 790 Bay St, Toronto, Canada ON M5G 1N8
    Med Hypotheses 69:1080-4. 2007
    ..It is our contention that certain nutritional factors, a weakened antioxidant defense system and altered intestinal microflora may interplay to increase the risk of psychological sequelae in acne vulgaris...
  12. ncbi request reprint Venlafaxine in the treatment of anxiety disorders
    Martin Katzman
    University of Toronto, Toronto, Canada
    Expert Rev Neurother 4:371-81. 2004
    ..Generally well-tolerated with side effects that usually abate with continued treatment, venlafaxine is an important alternative to the selective serotonin reuptake inhibitors for patients with anxiety disorders...
  13. ncbi request reprint Did a switch to a generic antidepressant cause relapse?
    Jessica Rosenthal
    START Clinic for Mood and Anxiety Disorders, Toronto, Ontario
    J Fam Pract 57:109-14. 2008
  14. ncbi request reprint The role of atypical antipsychotics in bipolar depression and anxiety disorders
    Roger McIntyre
    Mood Disorder Psychopharmacology Unit, University of Toronto, University Health Network, Toronto Western Hospital, 399 Bathurst Street, ECW 3D 003, Toronto, Ontario, M5T 2S9, Canada
    Bipolar Disord 5:20-35. 2003
    ..Thus, atypical antipsychotics represent an important therapeutic option for the treatment of bipolar disorder, providing improvements in manic, depressive, and anxiety symptoms...
  15. ncbi request reprint Herbs for mental illness: effectiveness and interaction with conventional medicines
    Monica Vermani
    Stress, Trauma, Anxiety, Rehabilitation Treatment Clinic for Mood and Anxiety Disorders, Toronto, Ontario, Canada
    J Fam Pract 54:789-800. 2005